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The (guanine-N7)-methyltransferase domain of the vaccinia virus mRNA capping enzyme is a heterodimer composed of a
catalytic subunit D1(498–844) bound to a stimulatory subunit D12. To identify structural elements of the 287-amino-acid D12
subunit that participate in binding and activation of the catalytic subunit, we introduced 12 double-alanine mutations at vicinal
residues that are conserved in the D12 homologs of other vertebrate poxviruses. His-tagged D12 mutants were coexpressed in
bacteria with the D1(498–544) subunit, and the recombinant D1(498–844)/His-D12 heterodimers were purified. Eight of the
mutants (K111A-R112A, N120A-N121A, N126A-N127A, F141A-R142A, K223A-D224A, H260A-S261A, E275A-N276A, and R280A-
R281A) had no significant effect on methyltransferase activity. Three of the mutants (L61A-K62A, F176A-K177A, and F245A-L246A)
displayed an intermediate level of cap methylation (35–50% of wild-type activity). Only one mutation, N42A-Y43A, elicited a
significant loss of the methyltransferase activation function (,20% of the wild-type activity). Nine of the D12-Ala/Ala proteins were
produced individually in bacteria and tested for reconstitution of methyltransferase activity in vitro by mixing with the catalytic
subunit. K111A-R112A, N120A-N121A, F176A-K177A, F245A-L246A, and L61A-K62A displayed diminished affinity for the D1
catalytic subunit. N42A-Y43A was uniquely defective in its ability to activate cap methylation by the catalytic subunit. Our results
suggest that the methyltransferase activation function of D12, though clearly dependent on the physical interaction with D1, also
requires constituents of D12 that are engaged specifically in catalysis. © 2001 Academic Pressc
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Vaccinia virus mRNAs contain a 59-terminal cap structure
7GpppN, which is synthesized by the sequential action of
hree viral enzymes—RNA triphosphatase, RNA guanylyl-
ransferase, and RNA (guanine-N7)-methyltransferase
Martin and Moss, 1975; Venkatesan et al., 1980). All three
atalytic domains are organized in a modular fashion within
single virus-encoded capping enzyme—a heterodimer of
7- and 33-kDa subunits encoded by the vaccinia D1 and
12 genes, respectively. The amino-terminal 60 kDa of the
1 subunit is an autonomous unit containing the guanylyl-
ransferase and triphosphatase activities (Shuman, 1989;
human and Morham, 1990; Myette and Niles, 1996a,b).
he active sites for the triphosphatase and guanylyltrans-
erase are nonoverlapping and have been mapped by site-
irected mutagenesis (Cong and Shuman, 1993; Niles and
hristen, 1993; Cong and Shuman, 1995; Yu and Shuman,
996; Yu et al., 1997; Ho et al., 2000). The methyltransferase
omain is a distinct, autonomous unit consisting of the
arboxyl portion of the D1 subunit heterodimerized with the
12 subunit (Cong and Shuman, 1992; Higman et al., 1992).
The contributions of the individual subunits to the cap
ethyltransferase domain have been examined by ex-
ressing the D1 and D12 polypeptides in bacteria. The
1 To whom reprint requests should be addressed. Fax: (212) 717-
623. E-mail: s-shuman@ski.mskcc.org.0042-6822/01 $35.00
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40arboxyl-terminal segment of the D1 polypeptide has a
eak intrinsic methyltransferase activity that can be
timulated 30- to 50-fold by the addition of purified D12
rotein, which is itself catalytically inert (Higman et al.,
994; Mao and Shuman, 1994). Therefore, the catalytic
enter must reside within the D1 protein. The C-terminal
egment of the D1 polypeptide contains binding sites for
NA, for S-adenosylmethionine (AdoMet; the methyl do-
or), and for GTP and the cap guanylate (which are
ethyl acceptors) (Luo and Shuman, 1993; Higman et al.,
994; Higman and Niles, 1994; Niles et al., 1994; Mao and
human, 1996). Moreover, the C-terminal domain of the
accinia D1 protein displays overt amino acid sequence
imilarity to the monomeric cap methyltransferases of
ungi and metazoans (Mao et al., 1995; Wang and Shu-
an, 1997; Saha et al., 1999). A mutational analysis of the
1 component of the methyltransferase domain identi-
ied three residues at which alanine substitution elimi-
ated or drastically reduced methyltransferase activity,
ut did not affect the interaction of the mutant D1 with its
12 partner (Mao and Shuman, 1996). Two of the side
hains that are essential for the vaccinia methyltrans-
erase are conserved in cellular cap-methylating en-
ymes and essential for their activity (Mao et al., 1996;
Wang et al., 1997; Saha et al., 1999).
The mechanism by which the D12 subunit stimulates
the cap methylation by the D1 subunit is not understood;
crosslinking studies have shown that D12 does not affect
41VACCINIA VIRUS CAP METHYLTRANSFERASEthe binding of either the methyl donor or the methyl
acceptor to the catalytic subunit (Niles et al., 1994; Hig-
man and Niles, 1994). Virtually nothing is known about
the structure–function relationships of the D12 subunit.
Preliminary experiments showed that deletions of the
287-amino-acid D12 subunit from the amino terminus (by
60 amino acids) or the carboxyl terminus (by 48 amino
acids) eliminated D12 interaction with the D1 subunit (as
gauged by coimmunoprecipitation). The truncated D12
subunits also did not stimulate the methyltransferase
activity of the D1 subunit (Cong and Shuman, 1992). As
an alternative approach toward identifying functional do-
mains of the D12 protein, we have now performed a
limited alanine-cluster mutagenesis of D12 and have
assessed the mutational effects on cap methylation in
vitro.
RESULTS AND DISCUSSION
Mutagenesis strategy
The amino acid sequences of the capping enzyme
small subunits are available for multiple genera of ver-
tebrate poxviruses, including vaccinia virus (genus Or-
thopoxvirus), Yaba monkey tumor virus (Yatapoxvirus),
swinepox virus (Suipoxvirus), Shope fibroma virus and
myxoma virus (Leporipoxvirus), fowlpox virus (Avipoxvi-
rus), and molluscum contagiosum virus (Molluscipoxvi-
rus) (Fig. 1). However, a comparison of the primary struc-
tures provides little help in guiding a mutational analysis,
because 63% of the 287 residues of vaccinia D12 are
either identical or similar in all of the vertebrate poxvirus
homologs. Moreover, no other virus family encodes a
recognizable D12-like protein, not even African swine
fever virus, which does encode a homolog of the large
D1 subunit of vaccinia capping enzyme (Pena et al.,
1993). There are also no convincing D12-like proteins in
the available eukaryotic proteomes, even though all eu-
karyotic cells encode homologs of the methyltransferase
catalytic domain of D1. Therefore, in the absence of
strong phylogenetic clues (the primary structures of the
two insect poxvirus D12-like proteins shown in Fig. 1
were not available at the time this study was initiated),
we adopted a double-alanine cluster approach, whereby
pairs of vicinal amino acids were changed to Ala-Ala
dipeptides in the context of the full-length vaccinia D12
protein. Twelve double-alanine cluster mutations were
introduced at sites highlighted by the shaded boxes in
Fig. 1.
The wild-type and mutated D12 genes were cloned
into bacterial expression vectors so as to fuse the D12
polypeptide in-frame with a short N-terminal leader pep-
tide containing 10 tandem histidines. The recombinant
proteins were produced in bacteria as described by Mao
and Shuman (1994). Wild-type D12 and nine of the D12-
Ala/Ala mutants were purified from soluble bacterial ex-
tracts by Ni-agarose chromatography. SDS–PAGEshowed that the His-D12 polypeptide was the predomi-
nant species in each preparation (Fig. 2). Three of the
D12-Ala/Ala proteins (N126A-N127A, F141A-R142A, and
H260A-S261A) were completely insoluble and thus could
not be purified for functional analysis.
Mutational effects on in vitro reconstitution of cap
methyltransferase
The recombinant C-terminal methyltransferase do-
main of the vaccinia D1 capping enzyme subunit, His-
D1(498–844), displays feeble cap methyltransferase in
vitro. Reconstitution of the activity can be achieved sim-
ply by mixing the purified catalytic component with puri-
fied recombinant D12 (Mao and Shuman, 1994; Higman
et al., 1994). In the present study, we mixed D1(498–844)
with varying amounts of the wild-type D12 or D12-Ala/Ala
proteins and then assayed the ability of the mixtures and
of D1(498–844) alone to catalyze AdoMet-dependent
conversion of 32P cap-labeled poly(A) [GpppA(pA)n] to
methylated cap-labeled poly(A) [m7GpppA(pA)n] (Shuman,
1989). Wild-type D12 stimulated cap methylation by a
factor of 30, and the extent of stimulation was 85% of the
maximum at a 1:1 molar ratio of D12 to D1(498–844) (Fig.
3). This result attests to the avid interaction of the two
capping enzyme subunits in vitro.
We observed three classes of mutational effects on
the in vitro reconstitution of the vaccinia methyltrans-
ferase. One class of mutations, exemplified by E275A-
N276A, R280A-R281A, and K223A-D224A, had no signif-
icant effect on the extent of methyltransferase stimula-
tion at saturating D12 and had little or no effect on the
D12 concentration-dependence of the methyltransferase
activation (Fig. 3A). Thus, we surmise that the E275A-
N276A, R280A-R281A, and K223A-D224A mutations did
not significantly affect the affinity of D12 for the methyl-
transferase catalytic subunit. A second class of muta-
tions, which included K111A-R112A, N120A-N121A,
F176A-K177A, F245A-L246A, and L61A-K62A, affected the
D12 concentration-dependence of methyltransferase ac-
tivation, eliciting clear shifts-to-the-right in the D12 titra-
tion profiles (Fig. 3B). These results are indicative of
diminished affinity of the D12-Ala/Ala mutants for the D1
catalytic subunit, with little or only modest effects on the
final extents of methyltransferase activation. For exam-
ple, stimulation by F245A-L246A was linear with D12 up
to 10 fmol and plateaued at 20–40 fmol, with an increase
of 20-fold above the basal level of methylation by the D1
subunit alone. We estimate that the affinity for D1 was
reduced by about a factor of 4 and the effector function
was diminished only slightly. The K111A-R112A mutation
reduced affinity for D1 by about an order of magnitude,
but did not compromise the catalytic effector function
(Fig. 3B).
The third type of mutational effect was exemplified by
N42A-Y43A, which markedly impeded the methyltrans-
d by as
42 SAHA AND SHUMANferase activation function of D12 (Fig. 3A). The maximal
extent of stimulation by N42A-Y43A was fivefold. This
was achieved at between 10 and 20 fmol of D12 and did
not increase at 40 fmol of D12. Thus, the defect was not
simply attributable to diminished affinity of N42A-Y43A
for its partner subunit.
Coexpression of the catalytic subunit with D12
His-tagged wild-type D12 was expressed in bacteria
FIG. 1. Aligned primary structures of poxvirus D12-like proteins. Th
related polypeptides encoded by other poxviruses (GenBank accession
swinepox virus (sp) (L22012); myxoma virus (mv) (AF170726); Shope
fowlpox virus (fp) (AJ005163); Melanoplus sanguinipes entomopoxvirus
dipeptides of the vaccinia D12 protein that were mutated to alanine i
residues in the other aligned protein sequences wherever there is side
nine of the aligned vertebrate and insect poxvirus proteins are denotetogether with the non-tagged D1(498–844) catalytic sub-unit. Purification was achieved by Ni-affinity chromatog-
raphy, which selects for the His-tagged D12 subunit.
Polypeptides corresponding to His-D12 and D1(498–844)
were recovered after the affinity chromatography step
(Fig. 4, lane WT). As expected, the non-tagged catalytic
subunit migrated slightly faster than did the His-tagged
D1(498–844) polypeptide (Fig. 4). Note that the D12 sub-
unit was present in molar excess compared to D1(498–
844) (Fig. 4, lane WT). The catalytic subunit itself is poorly
o acid sequence of the vaccinia virus (vv) D12 protein is aligned with
rs indicated in parentheses): Yaba monkey tumor virus (yv) (AB015885);
virus (sf) (AF170722); molluscum contagiosum virus (mc) (U60315);
F063866); and Amsacta moorei entomopoxvirus (Am) (AF250284). The
resent study are highlighted in shaded boxes; the boxes encompass
identity or similarity. Positions of side chain identity or similarity in all
terisks.e amin
numbe
fibroma
(Ms) (A
n the p
chainexpressed and poorly soluble in bacteria, but is stabi-
43VACCINIA VIRUS CAP METHYLTRANSFERASElized when it is coexpressed with the D12 protein, which
is itself reasonably soluble and stable in bacteria. The
D12 protein is more abundant than the catalytic subunit
when the two are coexpressed and the affinity purifica-
tion selects for the D12 component (Fig. 4), whereas
coexpression of the two proteins with the tag on the
catalytic subunit yields an equimolar mixture after the
FIG. 2. Purification of recombinant D12 and D12-Ala/Ala mutants. The
polypeptide compositions of the Ni-agarose eluate fractions of His-D12
and His-D12-Ala/Ala mutants were assessed by SDS–PAGE. Aliquots (4
mg) of the indicated preparations were electrophoresed through a 12%
polyacrylamide gel. Polypeptides were visualized by staining with Coo-
massie blue. The positions and sizes (kDa) of coelectrophoresed
marker polypeptides are indicated on the left.
FIG. 3. Reconstitution of cap methyltransferase in vitro. The extent o
of the amount of the wild-type D12 or D12-Ala/Ala subunits included in
independent experiments. The titration results are plotted in two graphs for caffinity chromatography step (not shown). To assess the
quaternary structure of the coexpressed subunits, we
sedimented the Ni-agarose preparation in a glycerol
gradient together with internal standards catalase, BSA,
and cytochrome c. The D1(498–844) polypeptide sedi-
mented as a discrete peak in fraction 19–21 coincident
with BSA (68 kDa); the catalytic subunit was associated
with a minority of the input D12 protein, apparently as a
1:1 heterodimer (Fig. 5). The “excess” D12 sedimented as
a monomer between BSA and cytochrome c.
We coexpressed all twelve of the D12-Ala/Ala mutants
in bacteria with the D1(498–844) catalytic subunit. The
coexpression strategy now permitted the recovery from
soluble extracts of the three mutated D12 proteins
(N126A-N127A, F141A-R142A, and H260A-S261A) that
were entirely insoluble when expressed on their own.
SDS–PAGE analysis of the Ni-agarose fractions is shown
in Fig. 4; note that the amount of protein applied to each
lane was normalized to include similar amounts of the
catalytic subunit D1(498–844). Although some of the af-
finity-selected His-D12-Ala/Ala proteins were, like wild-
type D12, present in excess over the catalytic subunit
(e.g., R280A-R281A, N120A-N121A, and N42A-Y43A),
other mutants were recovered in equimolar amounts
with D1(498–844), including N126A-N127A, F141A-R142A,
and H260A-S261A, F176A-K177A, F245A-L246A, and
L61A-K62A (Fig. 4). These mutants may be less stable or
less soluble than wild-type D12 in bacteria, such that
their extent of production when coexpressed is limited to
the fraction of the mutant D12 that associates with
D1(498–844).
ethylation by 2.5 fmol of the catalytic subunit is plotted as a function
ethyltransferase reaction mixtures. Each datum is the average of twof cap m
the mlarity.
44 SAHA AND SHUMANMethyltransferase activity of coexpressed capping
enzyme subunits
Cap methylation was assayed for each of the coex-
pressed D1(498–844)/His-D12 preparations and for the
catalytic subunit alone. The amount of enzyme added to
the reactions was adjusted to attain the same input level
of the D1(498–844) subunit. The coexpressed methyl-
transferase containing wild-type D12 was about 40-times
more active than the catalytic subunit alone (Fig. 6).
Three classes of mutational effects were observed. Eight
of the D12-Ala/Ala mutants (K111A-R112A, N120A-N121A,
N126A-N127A, F141A-R142A, K223A-D224A, H260A-
S261A, E275A-N276A, and R280A-R281A) had no signifi-
cant effect on methyltransferase activity, i.e., the coex-
pressed methyltransferase containing these D12 mu-
tants was at least 75% as active as the wild-type
preparation (Fig. 6). Analysis of the K111A-R112A protein
by glycerol gradient centrifugation showed that the
D1(498–844) and K111A-R112A polypeptides cosedi-
mented as a discrete 1:1 heterodimer at the leading
(heavy) edge of the BSA marker peak (Fig. 7D). There
was no excess “free” His-D12(K111A-R112A) detected in
the lighter fractions between BSA and cytochrome c,
which confirms our inference from the SDS–PAGE anal-
ysis of the Ni-agarose fraction (Fig. 4) that K111A-R112A
production in bacteria coexpressing the methyltrans-
ferase catalytic domain is limited to the fraction of the
FIG. 4. Coexpression of methyltransferase subunits in bacteria. The
coexpressing His-D12 and D1(498–844) were assessed by SDS–PAGE.
analyzed in parallel. Polypeptides were visualized by staining with Coo
polypeptides are indicated on the left. The positions of the D1(498–844
on the right.mutant D12 that associates with D1(498–844).Three of the mutants—L61A-K62A, F176A-K177A, and
F245A-L246A—displayed an intermediate level of cap
methylation (35–50% of wild-type activity) (Fig. 6). These
three protein preparations were analyzed by glycerol
gradient centrifugation (Fig. 7). The L61A-K62A (Fig. 7A),
F176A-K177A (Fig. 7B), and F245A-L246A (Fig. 7C) pro-
teins each sedimented as a discrete peak in a 1:1 com-
plex with the methyltransferase catalytic subunit, at the
leading edge of the BSA marker peak in the glycerol
gradient. Free mutant D12 protein was not detected (Fig.
7). We infer that the diminished activity of these three
mutant enzymes in cap methylation is not attributable to
dissociation of the coexpressed subunits.
Only one mutation, N42A-Y43A, elicited a significant
loss of the methyltransferase activation function, such
that the coexpressed methyltransferase containing
N42A-Y43A was less than 20% as active as the wild-type
enzyme (Fig. 6). Confirmation that the D1(498–844) sub-
unit was actually bound to the N42A-Y43A mutant D12
subunit was obtained by glycerol gradient sedimentation
analysis (Fig. 5). The catalytic subunit sedimented as a
discrete peak in fractions 17–21 together with the “heavy
shoulder” of the N42A-Y43A mutant, consistent with a 1:1
heterodimer. The excess N42A-Y43A protein sedimented
as a monomer between BSA and cytochrome c. We
surmise that the N42A-Y43A mutant is capable of binding
to the catalytic subunit, but is impaired in stimulating the
eptide compositions of the Ni-agarose eluate fractions from bacteria
ot of the Ni-agarose fraction of singly expressed His-D1(498–844) was
blue dye. The positions and sizes (kDa) of coelectrophoresed marker
], His-D1(498–844) [His-D1D], and His-D12 polypeptides are indicatedpolyp
An aliqu
massie
) [D1Dmethyltransferase reaction.
p45VACCINIA VIRUS CAP METHYLTRANSFERASEStructure-activity relationships for the D12 protein
We used two assay methods to gauge mutational
effects on the D12 component of vaccinia cap methyl-
transferase; the assays provide complementary informa-
tion on the structural requirements for D12 binding to the
catalytic subunit and D12 activation of the catalytic sub-
unit. The reconstitution of methyltransferase activity from
separately expressed catalytic and regulatory subunits
provides insights into the affinity of mutant D12 proteins
for the catalytic subunit and the extent of methyltrans-
ferase stimulation at saturating levels of D12. A limitation
of this approach, encountered in this study, is that some
D12 mutations affect the solubility of the recombinant
protein expressed by itself, thereby hampering purifica-
tion and reconstitution in vitro. However, we could cir-
cumvent this problem by coexpressing the catalytic and
regulatory subunits in vivo in bacteria and purifying the
His-tagged methyltransferase complex. The activity of
the methyltransferase complex formed in vivo from co-
FIG. 5. Glycerol gradient sedimentation of coexpressed D1(498–844) and
lus D1(498–844) or His-D12(N42A-Y43A) plus D1(498–844) were mixed w
0.2 ml of buffer A containing 0.2 M NaCl. The mixtures were applied to 4.
were centrifuged at 50,000 rpm in a Beckman SW50 rotor for 15 h at 4°C
ml) of alternate fractions were analyzed by SDS—PAGE, and the polypepexpressed subunits, when adjusted for equal amounts ofinput catalytic subunit, specifically illuminates mutational
effects on the activation function of the D12 protein,
independent of potential effects on subunit interaction.
It is therefore satisfying that the two assays yield
similar structure–function insights. The three cluster mu-
tants that retained activity in methyltransferase reconsti-
tution in vitro (E275A-N276A, R280A-R281A, and K223A-
D224A) also retained activity when they were coex-
pressed with D1(498–844). These findings imply that
none of the six substituted side chains contributes ap-
preciably to the D12 side of the subunit interface or to
D12 activation of the catalytic subunit.
Five cluster mutants displayed reduced binding affinity
for the catalytic subunit in the reconstitution assay: L61A-
K62A, K111A-R112A, N120A-N121A, F176A-K177A, and
F245A-L246A. The simplest interpretation of the result is
that one or both of the side chains in the mutated dipep-
tides is a component of the heterodimerization surface of
D12. The mapping of affinity mutations to widely sepa-
liquots (30 mg) of the Ni-agarose protein preparations of wild-type His-D12
rker proteins catalase (40 mg), BSA (40 mg), and cytochrome c (40 mg) in
–30% glycerol gradients containing 0.2 M NaCl in buffer A. The gradients
ns (;0.15 ml) were collected from the bottoms of the tubes. Aliquots (20
ere visualized by staining with Coomassie blue dye.D12. A
ith ma
8-ml 15
. Fractio
tides wrated loci in the D12 primary structure hints that multiple
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46 SAHA AND SHUMANelements contribute to the tertiary structure of the sub-
unit interface. We cannot exclude the possibility that loss
of affinity for the catalytic subunit is caused by indirect
effects on the local conformation of the D12-Ala/Ala pro-
teins. Global conformational effects are an unlikely ex-
planation for the diminished subunit affinity of L61A-
K62A, K111A-R112A, N120A-N121A, F176A-K177A, and
F245A-L246A, insofar as each retains full or partial ability
to stimulate the cap methylation when mixed in vitro with
he catalytic subunit. In the coexpression context, two of
he low-affinity mutants were near fully active (K111A-
112A and N120A-N121A), whereas the other three affin-
ty mutants (L61A-K62A, F176A-K177A, and F245A-L246A)
ere one-half to one-third as active as the wild-type
reparation.
The most illuminating mutant was N42A-Y43A, which
as clearly defective in activating the catalytic subunit
ndependent of any gross effects on the subunit interac-
ion. Thus, whereas subunit heterodimerization is clearly
equired for stimulation of cap methylation, it is not suf-
icient. Our data provide the first evidence that the meth-
ltransferase activation function is mediated by a distinct
unctional domain that, whether or not it is actually inde-
endent of the heterodimerization surface, consists of
dditional components engaged uniquely in catalysis.
he simplest inference is the Asn42-Tyr43 dipeptide is
tself a component of the activation domain.
Finally, it is worth noting that the present mutational
nalysis of D12 was initiated when phylogenetic com-
arisons were only available for D12-like proteins from
ertebrate poxviruses. The sequencing of the genomes
f two classes of insect poxviruses, Amsacta moorei
FIG. 6. Cap methylation by coexpressed D1(498–844) and D12. Meth-
yltransferase reaction mixtures contained 15 fmol of cap-labeled
poly(A) and ;2.5 fmol of D1(498–844) from the preparations of D1(498–
844) plus His-D12, D1(498–844) plus the indicated His-D12-Ala/Ala
mutants, or His-D1(498–844) alone (-D12). The values shown for the
extent of cap methylation are the averages of three experiments.ntomopoxvirus and Melanoplus sanguinipes ento-opoxvirus, uncovered D12-like proteins that display
onsiderable divergence in primary structure compared
o the vertebrate poxvirus proteins. Indeed, many of the
esidues mutated in the present study are not conserved
n the entomopoxviruses (Fig. 1). The notable exceptions
re: Tyr43, a putative component of the methyltrans-
erase activation domain, which is invariant in all of the
oxviruses; the Phe245–Leu246 dipeptide implicated in
FIG. 7. Glycerol gradient sedimentation. Aliquots of the Ni-agarose
protein preparations of D1(498–844) coexpressed with His-D12/Ala-Ala
mutants L61A-K62A (A), F176A-K177A (B), F245A-L246A (C), or K111A-
R112A (D) were mixed with marker proteins and sedimented in a
glycerol gradients as described in Fig. 5. Alternate fractions were
analyzed by SDS–PAGE, and the polypeptides were visualized by stain-
ing with Coomassie blue dye.
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47VACCINIA VIRUS CAP METHYLTRANSFERASEsubunit affinity, which is conserved as a hydrophobic
dipeptide; and Phe176, a putative component of the sub-
unit interface, which is conserved as an aromatic side
chain (Fig. 1). Of course, it remains to be established
whether the entomopoxvirus D12-like proteins are com-
ponents of their respective capping enzymes and
whether the D12-like proteins share the allosteric func-
tion in cap methylation characteristic of the vaccinia D12
protein. Nonetheless, the alignment of vertebrate and
invertebrate poxvirus D12-like proteins shown in Fig. 1
can provide a blueprint for further mutagenesis studies
and for the interpretation of structural data when D12 is
ultimately crystallized.
MATERIALS AND METHODS
Mutagenesis
Double-alanine mutations in the D12 protein were pro-
grammed by synthetic oligonucleotides using the two-
stage PCR-based overlap extension strategy. Plasmid
pET14-His-D12 (Mao and Shuman, 1994) was used as
the template for the first stage of amplification by Pfu
DNA polymerase. The reaction products were gel-puri-
fied and used for a second stage of amplification primed
by oligonucleotides flanking the His-D12 expression cas-
sette. NdeI–HindIII restriction fragments of the PCR-am-
lified genes containing the mutated D12 gene were
nserted into the T7 RNA polymerase-based vector
ET16b to yield a series of pET16-D12-Ala/Ala plasmids.
he presence of the desired mutation was confirmed by
equencing of plasmid DNAs isolated from individual
mpicillin-resistant E. coli transformants. The entire in-
sert was sequenced to exclude occurrence of unwanted
mutations during amplification or cloning. The wild-type
D12 gene was also transferred into the pET16b vector to
yield pET16-D12. Plasmids for coexpression of the cata-
lytic subunit D1(498–844) with wild-type or mutant D12
proteins were constructed by excising the D1(498–844)
expression cassette from pET-CD1 (Cong and Shuman,
1992) by digestion with BglII and HindIII and then insert-
ing the cassette between the BamHI and HindIII sites of
the pET16-D12 and pET16-D12-Ala/Ala plasmids. In
these coexpression plasmids, the two vaccinia genes
are driven by separate tandemly oriented T7 promoters.
The pET16-D12, pET16-D12-Ala/Ala, pET16-D12–D1(498–
844), and pET16-D12-Ala/Ala–D1(498–844) plasmids
were transformed into E. coli BL21(DE3).
Enzyme purification
E. coli BL21(DE3)/pET transformants were inoculated
into LB medium containing 0.1 mg/ml ampicillin and
grown at 37°C until the A600 reached approximately 0.4.
he cultures (500 ml) were placed on ice for 30 min,
djusted to 0.4 mM IPTG and 2% ethanol, and subse-
uently incubated for 18–20 h at 18°C with continuoushaking. Cells were harvested by centrifugation and the
ellets were stored at 280°C. All subsequent proce-
ures were performed at 4°C. Thawed cells were resus-
ended in 50 ml of lysis buffer (50 mM Tris–HCl, pH 7.5,
.5 M NaCl, 10% glycerol). Cell lysis was achieved by
ddition of lysozyme and Triton X-100 to final concentra-
ions of 0.25 mg/ml and 0.1%, respectively. Insoluble
aterial was removed by centrifugation at 18,000 rpm for
0 min in a Sorvall SS34 rotor. The supernatants were
ixed for 1 h with 2 ml of Ni-NTA-agarose resin (Qiagen)
hat had been equilibrated with lysis buffer. The slurries
ere poured into a column and then washed with lysis
uffer. The columns were eluted stepwise with IMAC
uffer (50 mM Tris–HCl, pH 8.0, 0.15 M NaCl, 1 mM
MSF, 10% glycerol, 0.1% Triton X-100) containing 25, 50,
00, and 500 mM imidazole. The polypeptide composi-
ions of the column fractions were monitored by SDS–
AGE. The recombinant vaccinia proteins were recov-
red in the 200 mM imidazole eluate fractions. The elu-
tes were dialyzed against 0.15 M NaCl in buffer A (50
M Tris–HCl, pH 8.0, 1 mM DTT, 10% glycerol, 0.1% Triton
-100). The total protein concentrations were determined
y using the Bio-Rad dye reagent with bovine serum
lbumin as a standard. The concentrations of D1(498–
44) in the fractions containing His-D12 plus D1(498–
44) were determined by SDS–PAGE analysis of protein
amples (13 and 23) in parallel with 1, 2, 3, and 4 mg of
ovine serum albumin. The gels were fixed and stained
ith Coomassie blue dye. The staining intensities of the
1(498–844) polypeptides were quantitated with a Digi-
al Imaging and Analysis System (Alpha Innotech Corpo-
ation). D1(498–844) concentrations were calculated by
xtrapolation to the BSA standard curve.
ethyltransferase reconstitution and assay of activity
An aliquot (10 ml) of purified His-D1(498–844) contain-
ng ;25 fmol of the catalytic subunit was mixed with a
0-ml aliquot containing either 0, 25, 50, 100, 200, or 400
mol of the purified His-D12 or His-D12-Ala/Ala proteins.
he mixtures were preincubated on ice for 15 min and
liquots (2 ml) containing ;2.5 fmol of the catalytic sub-
unit were assayed for cap methylation in reaction mix-
tures (10 ml) containing 50 mM Tris–HCl, pH 7.5, 5 mM
DTT, 50 mM AdoMet, and 15 fmol of 32P cap-labeled
poly(A). The mixtures were incubated at 37°C for 5 min.
The methylation reactions were quenched by heating to
95°C for 5 min. The reaction mixtures were adjusted to
50 mM sodium acetate (pH 5.5) and then digested with 5
mg of nuclease P1 for 60 min at 37°C. The digests were
then spotted on polyethyleneimine cellulose TLC plates
that were developed with 0.35 M (NH4)2SO4. The extent
f methylation of the cap [expressed as m7GpppA/
(m7GpppA 1 GpppA)] was determined by scanning the
chromatogram with a phosphorimager.
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